An Acceptable Incidence of Infusion Site Reactions after Subcutaneous Bortezomib Administration in the Upper Arm in Japanese Patients with Multiple Myeloma

被引：1
|
作者：
Ohgiya, Daisuke [1 ]
Tsuchiya, Takahide [1 ]
Suyama, Takahiro [1 ]
Watanabe, Shigeki [1 ]
Numata, Hiroki [2 ]
Tsuboi, Kosuke [2 ]
Sasao, Tamotsu [2 ]
机构：
[1] Ebina Gen Hosp, Dept Hematol, Ebina, Kanagawa 2430433, Japan
[2] Ozawa Hosp, Dept Hematol, Odawara, Kanagawa, Japan
来源：
ACTA HAEMATOLOGICA | 2015年 / 133卷 / 01期
关键词：
D O I：
10.1159/000362587
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：29 / 30
页数：2
相关论文
共 44 条
  • [1] Injection site reaction after subcutaneous administration of bortezomib in Japanese patients with multiple myeloma
    Tomohiko Kamimura
    Toshihiro Miyamoto
    Shuichiro Takashima
    Noriko Yokota
    Yong Chong
    Yoshikiyo Ito
    Koichi Akashi
    International Journal of Hematology, 2012, 96 : 525 - 527
  • [2] Injection site reaction after subcutaneous administration of bortezomib in Japanese patients with multiple myeloma
    Kamimura, Tomohiko
    Miyamoto, Toshihiro
    Takashima, Shuichiro
    Yokota, Noriko
    Chong, Yong
    Ito, Yoshikiyo
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (04) : 525 - 527
  • [3] Higher incidence of injection site reactions after subcutaneous bortezomib administration on the thigh compared with the abdomen
    Kamimura, Tomohiko
    Miyamoto, Toshihiro
    Yokota, Noriko
    Takashima, Shuichiro
    Chong, Yong
    Ito, Yoshikiyo
    Akashi, Koichi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (02) : 157 - 161
  • [4] Intravenous (IV) bortezomib infusion after non-response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?
    Gozzetti, Alessandro
    Candi, Veronica
    Brambilla, Corrado Zuanelli
    Papini, Giulia
    Bocchia, Monica
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (01) : 144 - 147
  • [5] Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma
    Moreau, Philippe
    Coiteux, Valerie
    Hulin, Cyrille
    Leleu, Xavier
    van de Velde, Helgi
    Acharya, Milin
    Harousseau, Jean-Luc
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (12): : 1908 - 1911
  • [6] Subcutaneous versus Intravenous Bortezomib Administration for Multiple Myeloma Patients:a Meta-analysis
    牟时代
    艾利莎
    秦铀
    胡豫
    Current Medical Science, 2018, 38 (01) : 43 - 50
  • [7] SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF BORTEZOMIB IN PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE IN A SINGLE INSTITUTION
    Lopez San Roman, I.
    De Miguel, D.
    Golbano, N.
    Diaz Morfa, M.
    Morales, D.
    Arbeteta, J.
    Herrero, S.
    Subira, D.
    Pinedo, B.
    HAEMATOLOGICA, 2012, 97 : 603 - 603
  • [8] Subcutaneous versus Intravenous Bortezomib Administration for Multiple Myeloma Patients: a Meta-analysis
    Shi-dai Mu
    Li-sha Ai
    You Qin
    Yu Hu
    Current Medical Science, 2018, 38 : 43 - 50
  • [9] Subcutaneous versus Intravenous Bortezomib Administration for Multiple Myeloma Patients: a Meta-analysis
    Mu, Shi-dai
    Al, Li-sha
    Qin, You
    Hu, Yu
    CURRENT MEDICAL SCIENCE, 2018, 38 (01) : 43 - 50
  • [10] COMPARATIVE EFFICACY OF SUBCUTANEOUS AND INTRAVENOUS ADMINISTRATION OF BORTEZOMIB IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Skvortsova, N.
    Pospelova, T.
    Kovynev, I.
    Nechunaeva, I.
    HAEMATOLOGICA, 2014, 99 : 657 - 657
12345